...
Product Theater – TREMFYA® (guselkumab): A First-line Biologic with Clinical Data vs Adalimumab and Secukinumab
June 7, 2019

Featuring Guest Faculty, Jeffrey Johnson, PA-C For Friday afternoon’s product theater, Jeffrey Johnson, PA-C , discussed psoriasis and treatment with Tremfya. Mr. Johnson reminded the audience psoriasis is not just an inflammatory skin disease but a global inflammatory disease which can affect all organ systems. For example, patients with moderate to severe psoriasis are 54% …

...
How Does the Microbiome Relate to Inflammatory Skin Diseases?
December 19, 2018

Studying the human microbiome, the collection of microorganisms that inhabit the human body, has allowed for advances in understanding the role of these microorganisms in disease and overall health. In addition, it has raised questions about whether manipulating the microbiome could result in expanded treatment options. Current research is underway to characterize the microbiome and …